Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Current HIV Research|July 30, 2025
Accelerating Innovation: Advancing Opportunities in HIV Vaccine DevelopmentCarlos A Diazgranados, Thandi Onami, Pervin AnklesariaAntioxidants & Redox Signaling|February 4, 2009
Redox modifier genes and pathways in amyotrophic lateral sclerosisBarrie J Carter, Pervin Anklesaria, Stephanie Choi, et al.The Journal of Rheumatology|March 17, 2010
Single-joint outcome measures: preliminary validation of patient-reported outcomes and physical examinationAlison E Heald, Edward J Fudman, Pervin Anklesaria, et al.The Journal of Gene Medicine|December 13, 2006
Calculating expected lung deposition of aerosolized administration of AAV vector in human clinical studiesKitty Leung, Emily Louca, Keith Munson, et al.Journal of Liposome Research|December 13, 2003
Targeting of lipid-protamine-DNA (LPD) lipopolyplexes using RGD motifsPierrot Harvie, Benjamin Dutzar, Todd Galbraith, et al.Vaccines|May 27, 2023
Experimental Medicine for HIV Vaccine Research and DevelopmentHolly Prudden, Roger Tatoud, Cathy Slack, et al.Cancer Gene Therapy|December 13, 2003
In vivo efficacy of folate-targeted lipid-protamine-DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinomaElizabeth Bruckheimer, Pierrot Harvie, Jason Orthel, et al.Vaccine|March 23, 2005
Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccineLauren M Tatalick, Christopher J Gerard, Ryan Takeya, et al.Cancer Research|November 20, 2002
Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A geneNaoto T Ueno, Chandra Bartholomeusz, Weiya Xia, et al.Head & Neck|July 12, 2002
A multicenter phase II study of tgDCC-E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinomaDoug Villaret, Bonnie Glisson, Daniel Kenady, et al.Pageof 2